Search Medical Condition
Please enter condition
Please choose location from dropdown

Additional Locations, Utah Clinical Trials

A listing of Additional Locations, Utah clinical trials actively recruiting patient volunteers.

RESULTS

Found (353) clinical trials

An Early Feasibility Evaluation of the AccuCinch Ventricular Repair System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study

This is a non-randomized, prospective, multi-center Early Feasibility Study to evaluate the AccuCinch Ventricular Repair System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF).

Phase N/A

8.57 miles

Learn More »

Early Feasibility Study of the AccuCinch Ventricular Repair System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study

This is a non-randomized, prospective, multi-center Early Feasibility Study of the AccuCinch Ventricular Repair System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation.

Phase N/A

8.57 miles

Learn More »

Meningitis Vaccine Research Opportunity Children aged 2 months are invited to join a Clinical Trial. Meningococcal meningitis is a serious illness that can occur at any age. It affects the covering of the brain and spinal cord.  It can also result in blood infection.  Vaccination is the best way to ...

Phase

8.57 miles

Learn More »

Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE)

The purpose of this study is to evaluate the safety and tolerability of V114 with respect to the proportion of participants with adverse events (AEs). The primary hypotheses are that 1) V114 is noninferior to Prevnar 13 as measured by the serotype specific OPA GMTs for 13 shared serotypes at ...

Phase

8.57 miles

Learn More »

If you are interested in learning more, please contact: Foothill Family Clinic (801-486-3021) 2295 Foothill Drive Salt Lake City, UT 84109 Foothill Family Clinic (801-365-1032) 6360 S 3000 E, Suite 100 Salt Lake City, UT 84121 FirstMed (801-733-4057) 1950 S 7000 E Salt Lake City, UT 84121 Jordan River Family ...

Phase

8.57 miles

Learn More »

If you are interested in more information, please talk to any of the medical staff or contact: Foothill Family Clinic 801-486-3021 Foothill Family Clinic South 801-365-1032 Jordan River Family Medicine 801-676-8109  

Phase

8.57 miles

Learn More »

Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine

The purpose of this study is to evaluate the efficacy and safety of eptinezumab administered intravenously in subjects experiencing an acute attack of migraine.

Phase

8.57 miles

Learn More »

A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease

This is a multicenter, Phase 3, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of etrolizumab compared with placebo during induction and maintenance treatment of moderately to severely active Crohn's Disease (CD). The target population includes participants with CD who are refractory or intolerant to corticosteroids (CS) and/or immunosuppressant ...

Phase

9.37 miles

Learn More »

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

This open-label extension and safety monitoring study is composed of two parts: Part 1 will evaluate the long-term safety and efficacy of continued etrolizumab treatment in participants with moderately to severely active Crohn's disease who were previously enrolled in the etrolizumab Phase III Study GA29144 (NCT02394028) and who meet eligibility ...

Phase

9.37 miles

Learn More »

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Phase N/A

9.37 miles

Learn More »